Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 113

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Ferric Carboxymaltose Injection in Reducing Anemia in Patients Receiving Chemotherapy for Non-Myeloid Malignancies: A Phase 3, Placebo-Controlled Study (IRON CLAD)

Jeffrey A. Gilreath, PharmD, Tamta Makharadze, MD, Ralph V. Boccia, MD, Anna Krupa, PharmD, David H. Henry, MD

Blood (2019) 134 (Supplement_1): 3535.

https://doi.org/10.1182/blood-2019-132135

Published: 2019

Journal Articles

Intravenous Fluid Boluses Are Commonly Administered to Adults with Sickle Cell Disease and Vaso-Occlusive Pain

Marcus A. Carden, MD, Paula Tanabe, PhDRN, Jeffrey A. Glassberg, MD

Blood (2019) 134 (Supplement_1): 4839.

https://doi.org/10.1182/blood-2019-121744

Published: 2019

Journal Articles

Mitigation of Vascular Permeability Using Bradykinin Receptor Antagonist and Anti-Fibrinolytic Agent in Rats with Polytrauma and Hemorrhagic Shock

Xiaowu Wu, MD MSc, Daniel N. Darlington, PhD, Josue Garciamarcano, Bin Liu, BS, Jeffrey D Keesee, BS, James Bynum, PhD, Andrew P. Cap, MD PhD

Blood (2019) 134 (Supplement_1): 2345.

https://doi.org/10.1182/blood-2019-130278

Published: 2019

Journal Articles

Benefit and Safety of Isovolemic Hemodilution Prior to Red Cell Exchange in Chronically Transfused Sickle Cell Patients

Katayoun Fomani, MD, Cindy Xu, Swathi Ratkal, MD, Vijay Nandi, PhD, Abena Appiah-Kubi, MD MPH, Banu Aygun, MD, James Louie, MD, Patricia Shi, MD

Blood (2019) 134 (Supplement_1): 2291.

https://doi.org/10.1182/blood-2019-122259

Published: 2019

Journal Articles

Use of Fluid and Oxygen Therapy in Normoaxaemic Paediatric Patients Presenting with Acute Sickle Vaso-Occlusive Episodes Requiring Hospital Admission and Analysis of Clinical Outcome

Zain Butt, BSc, Subarna Chakravorty, PhDFRCPath MRCP MRCPCH

Blood (2019) 134 (Supplement_1): 4844.

https://doi.org/10.1182/blood-2019-125708

Published: 2019

Journal Articles

Synergistic Effect of Carfilzomib and Metformin in Vascular Plasticity; The Emerging Role of Autophagy

Panagiotis Efentakis, PhD, Ioanna Andreadou, PhD, Panagiota-Efstathia Nikolaou, PhD, Claudius Witzler, Svenja Siemer, Eftathios Kastritis, Philip Wenzel, MD PhD, Meletios A. Dimopoulos, MD, Evangelos Terpos, MD PhD

Blood (2019) 134 (Supplement_1): 3797.

https://doi.org/10.1182/blood-2019-123522

Published: 2019

Journal Articles

Outpatient BEAM Using Daily Etoposide and Cytarabine with Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Is Feasible and Decreases Inpatient Length of Stay

Blood (2019) 134 (Supplement_1): 5830.

https://doi.org/10.1182/blood-2019-127402

Published: 2019

Journal Articles

Changes in Factor VIII:C Activity over 24 Hours Depending on Diluent and Storage Conditions after Dilution

Shin Young Hyun, MD, Kun soo Lee, MD PhD, Yu Ri Kim, MD

Blood (2018) 132 (Supplement 1): 2488.

https://doi.org/10.1182/blood-2018-99-120288

Published: 2018

Journal Articles

Adverse Events, Patterns of Tumor Lysis Syndrome Prophylaxis and Management, and Dosing Patterns in a Large Cohort of Venetoclax Treated CLL Patients in Community and Academic Settings

Blood (2018) 132 (Supplement 1): 4410.

https://doi.org/10.1182/blood-2018-99-118159

Published: 2018

Journal Articles

Co-Transplantation of Ucbmn with UC-MSC Enhances Engraftment of Ucbmn in Iron Overload NOD/SCID Mice

Zhi Huang, MMSc, Yuhua Xiao, Xiaomin Chen, Chunfu Li, MD, Xiaoqin Feng, PhD

Blood (2018) 132 (Supplement 1): 5674.

https://doi.org/10.1182/blood-2018-99-119834

Published: 2018

Journal Articles

Peritoneal Cavity Cells Ameliorate Graft-Versus-Host Disease of Mice after MHC Mismatched Bone Marrow Transplantation

Zhigang Liu, MD, Wanhua Zhang, MD, Xinchuan Chen, MD, Chuan He, MD, Jie Ji, MD, Ting Liu, MD

Blood (2018) 132 (Supplement 1): 5675.

https://doi.org/10.1182/blood-2018-99-114510

Published: 2018

Journal Articles

Painful Transitions—a Comparison of Acute Pain Management in Children, Adolescents and Young Adults with Sickle Cell Disease in Adjacent Pediatric and Adult Emergency Departments

Brian Pennarola, MD, Patrick Demartino, MD, Dale W. Steele, MD, Susan J. Duffy, MD

Blood (2018) 132 (Supplement 1): 4700.

https://doi.org/10.1182/blood-2018-99-117703

Published: 2018

Journal Articles

The Role of Thrombin Deficiency on Skeletal Health

Hillary J Taylor, BS, Galen Goldscheitter, BS, BA, Jason A Taylor, MD PhD

Blood (2018) 132 (Supplement 1): 5012.

https://doi.org/10.1182/blood-2018-99-118989

Published: 2018

Journal Articles

Safety of Split First Dosing Vs Standard Dosing Administration of Daratumumab Among Multiple Myeloma Patients Treated in a US Community Oncology Setting: A Real-World Observational Study

Robert M Rifkin, MD, David Singer, PharmD, Kathleen M. Aguilar, MPH, Bismark Baidoo, PhD, Eric M Maiese, PhD

Blood (2018) 132 (Supplement 1): 4846.

https://doi.org/10.1182/blood-2018-99-116808

Published: 2018

Journal Articles

A Phase II Study of the Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RVD) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma: Promising Activity and Manageable Toxicity, Including in High Risk Disease

Blood (2018) 132 (Supplement 1): 1981.

https://doi.org/10.1182/blood-2018-99-116280

Published: 2018

Journal Articles

Comparison of Second and First Generation of Andexanet Alfa in a Porcine Polytrauma Model with Apixaban Anticoagulation

Oliver Grottke, MD PhD MPH, Necib Akman, MD, Till Braunschweig, MD, Pamela B. Conley, PhD, Rolf Rossaint, MD

Blood (2018) 132 (Supplement 1): 3778.

https://doi.org/10.1182/blood-2018-99-114542

Published: 2018

Journal Articles

Disease and Patient Characteristics, Patterns of Care, Toxicities, and Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax: A Multicenter Study of 204 Patients

Anthony R. Mato, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, John N. Allan, MD, Danielle M. Brander, MD, John M. Pagel, MD PhD, Chaitra S. Ujjani, MD, Brian T. Hill, MD PhD, Nicole Lamanna, MD, Frederick Lansigan, MD, Ryan Jacobs, MD, Mazyar Shadman, MD, Alan P Skarbnik, MD, Jeffrey J. Pu, MD PhD, Paul M. Barr, MD, Alison R. Sehgal, MD, Bruce D. Cheson, MD, Clive S Zent, MD, Hande H. Tuncer, MD, Stephen J. Schuster, MD, Peter V. Pickens, MD, Nirav N Shah, MD, Allison M. Winter, MD, Kaitlin Kennard, RN, BSN, Krista Isaac, DO, MS, Colleen Dorsey, BSN, RN, Alexandra Marie Vandegrift, BA, Arun K Singavi, MD, Annalynn Williams, MS, Christina Howlett, PharmD, Hanna Weissbrot, BS, Naveed Ali, MD, Sirin Khajavian, MD, Andrea Sitlinger, MD, Eve Tranchito, BS, Joanna Rhodes, MD, Erica Bharat Bhavsar, BS, Neil Bailey, MS, Bhavisha Patel, MD, Timothy F. Burns, MD, Melissa Yacur, MD, Mansi Malhotra, BS, Sasanka Handunnetti, MD, Jakub Svoboda, MD, Richard R. Furman, MD, Chadi Nabhan, MD MBA, FACP

Blood (2017) 130 (Supplement 1): 4315.

https://doi.org/10.1182/blood.V130.Suppl_1.4315.4315

Published: 2017

Journal Articles

Therapy of Adults Affected By Idiopathic Thrombocytopenic Purpura with 3 Cycles Pulses of High-Dose Dexamethasone (HD-DXM): A Prospective Randomized Clinical Trial

Saeid Rezaei Jouzdani, MD

Blood (2017) 130 (Supplement 1): 3648.

https://doi.org/10.1182/blood.V130.Suppl_1.3648.3648

Published: 2017

Journal Articles

Coagulopathy As a Dose-Limiting Toxicity in Systemic Administration of Mesenchymal Stem Cells (MSCs): Relative Safety of Bone Marrow Versus Adipose Derived MSCs

Xiaowu Wu, MD MSc, Daniel N Darlington, PhD, Robbie K Montgomery, MS, Bin Liu, BS, Jeffrey D Keesee, BS, Josue Garciamarcano, Andres S Penagosnino, Andrew P. Cap, MD PhD

Blood (2017) 130 (Supplement 1): 3654.

https://doi.org/10.1182/blood.V130.Suppl_1.3654.3654

Published: 2017

Journal Articles

Interpretation of TEG Studies in Management of a Severe Glanzmann Thrombasthenia Patient

Paulette Bryant, MD, Katie Andricopulos, PharmD, BCPPS

Blood (2017) 130 (Supplement 1): 4854.

https://doi.org/10.1182/blood.V130.Suppl_1.4854.4854

Published: 2017

NARROW

Efficacy and Safety of Ferric Carboxymaltose Injection in Reducing Anemia in Patients Receiving Chemotherapy for Non-Myeloid Malignancies: A Phase 3, Placebo-Controlled Study (IRON CLAD)

Intravenous Fluid Boluses Are Commonly Administered to Adults with Sickle Cell Disease and Vaso-Occlusive Pain

Mitigation of Vascular Permeability Using Bradykinin Receptor Antagonist and Anti-Fibrinolytic Agent in Rats with Polytrauma and Hemorrhagic Shock

Benefit and Safety of Isovolemic Hemodilution Prior to Red Cell Exchange in Chronically Transfused Sickle Cell Patients

Use of Fluid and Oxygen Therapy in Normoaxaemic Paediatric Patients Presenting with Acute Sickle Vaso-Occlusive Episodes Requiring Hospital Admission and Analysis of Clinical Outcome

Synergistic Effect of Carfilzomib and Metformin in Vascular Plasticity; The Emerging Role of Autophagy

Outpatient BEAM Using Daily Etoposide and Cytarabine with Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Is Feasible and Decreases Inpatient Length of Stay

Changes in Factor VIII:C Activity over 24 Hours Depending on Diluent and Storage Conditions after Dilution

Adverse Events, Patterns of Tumor Lysis Syndrome Prophylaxis and Management, and Dosing Patterns in a Large Cohort of Venetoclax Treated CLL Patients in Community and Academic Settings

Co-Transplantation of Ucbmn with UC-MSC Enhances Engraftment of Ucbmn in Iron Overload NOD/SCID Mice

Peritoneal Cavity Cells Ameliorate Graft-Versus-Host Disease of Mice after MHC Mismatched Bone Marrow Transplantation

Painful Transitions—a Comparison of Acute Pain Management in Children, Adolescents and Young Adults with Sickle Cell Disease in Adjacent Pediatric and Adult Emergency Departments

The Role of Thrombin Deficiency on Skeletal Health

Safety of Split First Dosing Vs Standard Dosing Administration of Daratumumab Among Multiple Myeloma Patients Treated in a US Community Oncology Setting: A Real-World Observational Study

A Phase II Study of the Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RVD) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma: Promising Activity and Manageable Toxicity, Including in High Risk Disease

Comparison of Second and First Generation of Andexanet Alfa in a Porcine Polytrauma Model with Apixaban Anticoagulation

Disease and Patient Characteristics, Patterns of Care, Toxicities, and Outcomes of Chronic Lymphocytic Leukemia (CLL) Patients Treated with Venetoclax: A Multicenter Study of 204 Patients

Therapy of Adults Affected By Idiopathic Thrombocytopenic Purpura with 3 Cycles Pulses of High-Dose Dexamethasone (HD-DXM): A Prospective Randomized Clinical Trial

Coagulopathy As a Dose-Limiting Toxicity in Systemic Administration of Mesenchymal Stem Cells (MSCs): Relative Safety of Bone Marrow Versus Adipose Derived MSCs

Interpretation of TEG Studies in Management of a Severe Glanzmann Thrombasthenia Patient

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only